Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2722296 | 0.85 | EGFR (0.38) | GABRA1GABRB2TP53MGLL | |
| SCHEMBL983255 | 0.85 | SREBF2 (0.33) | L3MBTL1MAPTSMN1; SMN2PDCD1CD274 | |
| SCHEMBL982519 | 0.82 | LIPG (0.39) | CYP2D6 | |
| SCHEMBL15049712 | 0.80 | BCL2 (0.44) | GABRA1GABRB2TP53MGLL | |
| SCHEMBL981932 | 0.80 | LIPG (0.45) | TP53MAPTKMT2A | |
| SCHEMBL6928439 | 0.80 | CYP2D6 (0.41) | GABRA1GABRB2L3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL28033647 | 0.80 | DPP4 (0.50) | SMN1; SMN2CYP2D6DPP4 | |
| SCHEMBL7703138 | 0.80 | ALDH1A1 (0.34) | DPP4 | |
| SCHEMBL7698397 | 0.80 | PDCD1 (0.44) | L3MBTL1MAPTPDCD1CD274DPP4 | |
| SCHEMBL1664569 | 0.79 | GABRA1 (0.41) | GABRA1GABRB2PDCD1CD274KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2275406-B1 | PROCESS FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2018-11-28 | — | — | EP | disclosed |
| US-9233918-B2 | Isocyanate production process | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| CN-102026965-B | Method for producing isocyanate | ASAHI KASEI CHEMICALS CORP | 2014-02-26 | — | — | CN | disclosed |
| EP-2513125-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-10-24 | — | — | EP | disclosed |
| EP-2493906-A1 | HETEROLEPTIC CARBENE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2012-09-05 | — | — | EP | disclosed |
| US-7977504-B2 | Process for producing isocyanates and aromatic hydroxy compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-07-12 | — | — | US | disclosed |
| WO-2011073149-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011051404-A1 | HETEROLEPTIC CARBENE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2011-05-05 | — | — | WO | disclosed |
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| EP-2275406-A1 | PROCESS FOR PRODUCING ISOCYANATE | Asahi Kasei Chemicals Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20100274047-A1 | PROCESS FOR PRODUCING OF ISOCYANATES AND AROMATIC HYDROXY COMPOUNDS | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-10-28 | — | — | US | disclosed |
| EP-0977724-A1 | PROCESS FOR CHIRAL ENRICHMENT OF OPTICALLY ACTIVE CARBOXYLIC ACIDS, OR SALTS OR ESTERS THEREOF | ALBEMARLE CORPORATION (US) | 2000-02-09 | — | — | EP | disclosed |
| US-5936118-A | Process for chiral enrichment of optically active carboxylic acids or salts or esters thereof | ALBEMARLE CORPORATION (US) | 1999-08-10 | — | — | US | disclosed |
| EP-0925267-A1 | RACEMIZATION PROCESS FOR OPTICALLY ACTIVE CARBOXYLIC ACIDS OR SALTS OR ESTERS THEREOF | ALBEMARLE CORPORATION (US) | 1999-06-30 | — | — | EP | disclosed |
| US-5847202-A | Racemization process for optically active carboxylic acids or salts or esters thereof | ALBEMARLE CORPORATION (US) | 1998-12-08 | — | — | US | disclosed |
| WO-1998045240-A1 | PROCESS FOR CHIRAL ENRICHMENT OF OPTICALLY ACTIVE CARBOXYLIC ACIDS, OR SALTS OR ESTERS THEREOF | ALBEMARLE CORPORATION (US) | 1998-10-15 | — | — | WO | disclosed |
| WO-1997047572-A1 | RACEMIZATION PROCESS FOR OPTICALLY ACTIVE CARBOXYLIC ACIDS OR SALTS OR ESTERS THEREOF | ALBEMARLE CORPORATION (US) | 1997-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110092731-A1 | ISOCYANATE PRODUCTION PROCESS | CPS1, PHGDH, APEH | GABRA1 4305/4885GABRB2 3761/4885TP53 1912/4885 |
| US-20100274047-A1 | PROCESS FOR PRODUCING OF ISOCYANATES AND AROMATIC HYDROXY COMPOUNDS | PAH, APEH, HPD | GABRA1 2713/4885GABRB2 3296/4885TP53 2384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.